Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE-2: Sirolimus in Uveitis
NCT01280669Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in noninfectious uveitis (NIU), sponsored by Stanford University. Planned start Sep 2022; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT01280669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280669.